Baird raised the firm’s price target on LivaNova to $62 from $56 and keeps an Outperform rating on the shares. The firm sees potential for continued upside in 2H23 especially as new products roll out (Essenz) and growth trends in neuromod remain strong.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LIVN: